Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: Results of the PANCOSTABRAX study

  1. Carrato, A.
  2. García, P.
  3. Lopez, R.
  4. Macarulla, T.
  5. Rivera, F.
  6. Sastre, J.
  7. Gostkorzewicz, J.
  8. Benedit, P.
  9. Perez-Alcántara, F.
Revista:
Expert Review of Pharmacoeconomics and Outcomes Research

ISSN: 1744-8379 1473-7167

Ano de publicación: 2015

Volume: 15

Número: 4

Páxinas: 579-589

Tipo: Revisión

DOI: 10.1586/14737167.2015.1047349 GOOGLE SCHOLAR